Allarity Therapeutics Inc. – Filings and Transcripts

NASDAQ: ALLR
Share price (8/5/26): $1.33
Market cap (8/5/26): $20.6 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Late quarterly filing notification for Q2 2025

Prospectuses and Registrations Filter

Prospectus supplement

Shelf registration – amended

Shelf registration

Prospectus supplement for primary offering

Shelf registration

Ownership Filter

Hoeiland Jesper

Hoeiland Jesper

McLaughlin Gerald W.

Graff Jeremy R.

News Filter

Announces the Grant of Essential U.S. Patent for Its Stenoparib DRP® Companion Diagnostic

To Present Trial-In-Progress Poster on Phase 2 Stenoparib Trial at ESMO Gynaecological Cancers Congress 2026

Change in Directors, Officers or Compensation, Financial Statements or Exhibits

CEO to Present at Precision Medicine Forum Europe 2026 in Stockholm

Advances Stenoparib Toward Pivotal Development With Phase 3 Manufacturing Campaign

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness